Immunotherapy: iPSC-based cancer vaccine

Nature Reviews Drug Discovery 17, 242 (2018). doi:10.1038/nrd.2018.48 Author: Sarah Crunkhorn Pluripotent cells share antigens with cancer cells, suggesting that they could be used to prime the immune system to target cancer. Here, Kooreman and colleagues report the development of a vaccine based on irradiated mouse induced pluripotent stem cells. Prophylactically, the vaccine inhibited tumour growth
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Research Highlight Source Type: research